Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells Journal Article


Authors: Haddock, S.; Alban, T. J.; Turcan, Ş; Husic, H.; Rosiek, E.; Ma, X.; Wang, Y.; Bale, T.; Desrichard, A.; Makarov, V.; Monette, S.; Wu, W.; Gardner, R.; Manova, K.; Boire, A.; Chan, T. A.
Article Title: Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
Abstract: Mutations in IDH1 and IDH2 drive the development of gliomas. These genetic alterations promote tumor cell renewal, disrupt differentiation states, and induce stem-like properties. Understanding how this phenotypic reprogramming occurs remains an area of high interest in glioma research. Previously, we showed that IDH mutation results in the development of a CD24-positive cell population in gliomas. Here, we demonstrate that this CD24-positive population possesses striking stem-like properties at the molecular and phenotypic levels. We found that CD24 expression is associated with stem-like features in IDH-mutant tumors, a patient-derived gliomasphere model, and a neural stem cell model of IDH1-mutant glioma. In orthotopic models, CD24-positive cells display enhanced tumor initiating potency compared to CD24-negative cells. Furthermore, CD24 knockdown results in changes in cell viability, proliferation rate, and gene expression that closely resemble a CD24-negative phenotype. Our data demonstrate that induction of a CD24-positive population is one mechanism by which IDH-mutant tumors acquire stem-like properties. These findings have significant implications for our understanding of the molecular underpinnings of IDH-mutant gliomas. © 2022
Keywords: neural stem cells; cancer stem cells; low-grade glioma; idh1 mutation; cd24; orthotopic mouse model
Journal Title: NeoPlasia
Volume: 28
ISSN: 1522-8002
Publisher: Elsevier Science Inc.  
Date Published: 2022-06-01
Start Page: 100790
Language: English
DOI: 10.1016/j.neo.2022.100790
PROVIDER: scopus
PMCID: PMC9014446
PUBMED: 35398668
DOI/URL:
Notes: Article -- Export Date: 2 May 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. Sebastien Monette
    149 Monette
  3. Adrienne Boire
    106 Boire
  4. Wei Hang Wu
    11 Wu
  5. Tejus Bale
    122 Bale
  6. Eric Rosiek
    7 Rosiek